Risk of thyroid cancer and high prevalence of hepatitis C virus

Oncology Reports

Volumn 10, Issue 1, 2003, Pages 133-136

  Montella, Maurizio ^a   Pezzullo, Luciano ^a   Crispo, Anna ^a   Izzo, Francesco ^a   Amore, Alfonso ^a   Marone, Ugo ^a   Tamburini, Mario ^a   Ronga, Domenico ^a   Chiofalo, Maria Grazia ^a   Chiappetta, Gennaro ^a   Mozzillo, Nicola ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Case control study; Hepatitis C virus; Thyroid cancer; Virus infection

Indexed keywords

PRIMER DNA;

ADULT; ARTICLE; CASE CONTROL STUDY; CHEMISTRY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ITALY; MALE; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOGENICITY; POLYMERASE CHAIN REACTION; PREVALENCE; RISK; RISK FACTOR; THYROID TUMOR; VIROLOGY;

ADULT; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; ITALY; MALE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; THYROID NEOPLASMS;

EID: 0141745240     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.1.133     Document Type: Article

References (29)

1. Guadagnino V, Stroffolini T, Rapicetta M, et al: Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 26: 1006-1011, 1997. (Pubitemid 27413671)
2. Montella M, Buonanno M, Iannuzzo MT, et al: Trends of cancer mortality in Campania Region and in Italy, 1980-1993 and Incidence Campania Cancer Register 1996. In: Lega Italiana per la Lotta contro i Tumori. National Cancer Institute, Naples, 1998.
3. Montella M, Bidoli E, De Marco MR, et al: High mortality rates from liver cancer in the urban area of Campania Region: prevalence of hepatitis and sociodemographic factors. Oncol Rep 5: 165-169, 1998. (Pubitemid 28039840)
4. Tagger A, Donato F, Ribero ML, et al: Case-control study on hepatitis C virus (HCV) as risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alchol. Int J Cancer 81: 695-699, 1999. (Pubitemid 29214375)
5. Ferri C, La Civita L, Zignego AL and Pasero G: Viruses and cancers: possible role of hepatitis C virus. Eur J Clin Invest 27: 711-718, 1997. (Pubitemid 27414411)
6. Heintges T and Wands JR: Hepatitis C virus: epidemiology and transmission. Hepatology 26: 521-526, 1997. (Pubitemid 27392339)
7. Oshawa M, Shingu N, Miwa H, et al: Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection. Int I Cancer 60: 237-239, 1999. (Pubitemid 29001727)
8. Silvestri F: Hepatitis C virus-related lymphomas. Br J Haematol 99: 475-480, 1997.
9. Wagner B, Vierhapper H and Hofman H: Prevalence of hepatitis C virus infection in Hashimoto's thyroiditis. Br Med J 312: 640-641, 1996. (Pubitemid 26079615)
10. Montella M, Crispo A, Russo F, Ronga D, Tridente V and Tamburini M: Hepatitis C virus infection and a new association with extrahepatic disease: multiple myeloma. Haematologica 85: 883-884, 2000.
11. Brelsow NE and Day NE: Statistical methods in cancer research. In: The Analysis of Case-Control Studies. Vol 1. IARC Sci Publ 32, Lyon, 1980.
12. Zanetti R, Crosignani P and Rosso S: Cancer in Italy incidence data from cancer registries 1988-1992. In: Lega Italiana per la Lotta contro i Tumori. Italian Association of Epidemiology, Roma, 1997.
13. Franceschi S, La Vecchia C and Bidoli E: High incidence of thyroid cancer in central Italy. Int J Cancer 77: 481-482, 1998. (Pubitemid 28299889)
14. Aghini-Lombardi F, Antonageli L, Martino E, et al: The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab 84: 561-566, 1999. (Pubitemid 29075684)
15. Ikeda K, Saitoh S, Koida I, et al: A multivariate risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18: 47-53, 1993. (Pubitemid 23193616)
16. Alter MJ, Kruszon-Moran D, Nainan OV, et al: The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341: 556-562, 1999. (Pubitemid 29384163)
17. Takano S, Yokosuka O, Imazeki F, et al: Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 21: 650-655, 1995.
18. Hadziyannis S, Tabor E, Kaklamani E, et al. A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma. Int J Cancer 60: 627-631, 1995.
19. Tanaka H, Hiyama T, Tsukuma H, et al: Cumulative risk of hepatocellular carcinoma in hepatitis C virus carriers: statistical estimations from cross-sectional data. Jpn J Cancer Res 85: 485-490, 1994. (Pubitemid 24164635)
20. Fernandez-Soto L, Gonzales A, Escobar-Jimenez F, et al: Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med 158: 1445-1448, 1998. (Pubitemid 28317761)
21. Huang MJ, Tsai SL, Scheen IS, et al: Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study. Clin Endocrinol 50: 503-509, 1999.
22. Okayasu I, Fujiwara M, Hara Y, et al: Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma: a study of surgical cases among lapanese, and white and African Americans. Cancer 76: 2313-2318, 1995.
23. Antonelli A, Ferri C and Fallahi P: Thyroid cancer in patients with hepatitis C infection. JAMA 281: 1588, 1999. (Pubitemid 29211765)
24. Williams ED: Thyroid tumorigenesis. Horm Res 42: 31-34, 1979.
25. Montella M, Crispo A, Frigeri F, Ronga D, Tridente V, De Marco MR, et al: HCV and tumors correlated with immune system: a case control study in an area of hyperendemicity. Leuk Res 25: 775-781, 2001. (Pubitemid 32727980)
26. Cacoub P, Renon C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, et al: Extraepatic manifestation associated with hepatitis C infection. A prospective multicenter study of 321 patients. Medicine 79: 47-56, 2000. (Pubitemid 30077736)
27. Williams ED: Mechanisms and pathogenesis of thyroid cancer in animals and man. Mutat Res 333: 123-129, 1995.
28. Tallini G, Santoro M, Helie M, et al: RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated and undifferentiated tumor phenotypes. Clin Cancer Res 4: 287-294, 1998. (Pubitemid 28122740)
29. Pacini F, Vivaldi A, Santoro M, et al: Simian virus 40-like DNA sequences in human papillary thyroid carcinomas. Oncogene 16: 665-669, 1998. (Pubitemid 28062347)